Merck & CompanyvsSANUWAVE Health

MRK and SNWV stock compared: price, dividend, valuation and results, from SEC filings.

MRK

Merck & Company, Inc.

$137.78

Value $341B

-3.90%
MRK's page

SNWV

SANUWAVE Health, Inc.

$1.71

Value $15M

+0.59%
SNWV's page

Merck & Company (MRK) has a market value of $341B and SANUWAVE Health (SNWV) $15M. Over the last year, with dividends, MRK moved +52.7% and SNWV -94.8%. The P/E is 138.9 for MRK and 3.5 for SNWV. Dividend yield: MRK 2.47%, SNWV none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    MRK$341B

    SNWV$15M

    MRK is 23,179 times SNWV

  • Revenue, 12 months

    MRK$67.4B

    SNWV$41M

    MRK is 1,630 times SNWV

  • Net income, 12 months

    MRK$2.5B

    SNWV$4.2M

    MRK is 590 times SNWV

  • Operating margin

    MRK–

    SNWV-1.1%

  • ROIC

    MRK3.9%

    SNWV-2.4%

    6.3 points apart

  • P/E

    MRK138.9

    SNWV3.5

    MRK is 39 times SNWV

  • Dividend yield

    MRK2.5%

    SNWV0.0%

    2.5 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

MRK+52.8%

SNWV-94.8%

050100150DecFebAprJunAugOct
Returns by period
PeriodMRKWith dividendsSNWVWith dividends
1 year since November 17, 2025+52.7%Price +48.4%-94.8%Price -94.8%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

MRKMerck & CompanySNWVSANUWAVE Health

Valuation

MRKSNWV
Valuation
Price$137.78$1.71
Market value$341B$15M
Enterprise value (EV)$385B$25M
P/E138.93.5
P/E, 5-year median14.8–
P/B7.65.2
EV/EBIT80.8–
Free cash flow yield4.3%17.7%

Results and growth

MRKSNWV
Results and growth
Revenue, 12 months$67.4B$41M
Net income, 12 months$2.5B$4.2M
Free cash flow, 12 months$14.7B$2.6M
Earnings per share, 12 months$0.98-$0.21
Revenue growth, year on year1.3%35.0%
Revenue growth a year, past+9.4%over 5 years+61.1%over 5 years
EPS growth a year, past+21.2%over 5 years–

Margins and returns on capital

MRKSNWV
Margins and returns on capital
Gross margin71.8%76.2%
Operating margin–-1.1%
Net margin3.6%10.1%
ROIC3.9%-2.4%
ROE5.2%1,383.2%

Balance sheet

MRKSNWV
Balance sheet
Cash$9.7B$6.6M
Total debt$53.8B$18M
Net debt / EBITDA5.720.0
Interest cover2.4×–

Dividends and buybacks

MRKSNWV
Dividends and buybacks
Dividend yield2.5%–
Dividend per share, 12 months$3.40–
Dividend growth a year, past+5.8%over 5 years–
Buyback yield1.5%–
Shareholder yield4.0%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: MRK or SNWV

Didn't find what you were looking for?

Ask us
Which is bigger, Merck & Company or SANUWAVE Health?

By market value, Merck & Company ($341B) is about 23,179.4 times SANUWAVE Health ($15M), at today's prices.

How did MRK and SNWV stock do over the last 1 years?

Since November 17, 2025, MRK's price moved +48.4% and SNWV's -94.8%. With dividends: MRK +52.7% (+52.7% a year), SNWV -94.8% (-94.8% a year). Past returns do not predict future ones.

Which pays the higher dividend, MRK or SNWV?

The dividend yield at today's price is 2.47% for Merck & Company and none for SANUWAVE Health. Over the last twelve months they paid $3.40 and – per share.

What is the P/E of MRK and SNWV?

At today's price, the P/E is 138.9 for MRK and 3.5 for SNWV. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Merck & Company or SANUWAVE Health?

Over the last twelve months, the net margin was 3.6% for Merck & Company and 10.1% for SANUWAVE Health, and the operating margin – and -1.1%. Revenue was $67.4B and $41M.

Which is the better investment, Merck & Company or SANUWAVE Health?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.